Chemomab Therapeutics Ltd. American Depositary Share
$2.80
$0.15 (+5.66%)
$2.56Day Range$2.80
Key Statistics
Market Cap
$19.42M
Shares Outstanding
7.3M
Primary Exchange
XNAS
Currency
USD
Type
ADRC
IPO Date
Mar 17, 2021
Round Lot
100
Locale
US
Trading Data
Day Open
$2.74
Day High
$2.80
Day Low
$2.56
Volume
130.7K
VWAP
$2.64
Prev Close
$2.65
Transactions
--
Acc. Volume
--
About Chemomab Therapeutics Ltd. American Depositary Share
Chemomab Therapeutics Ltd is a clinical-stage biotechnology company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin, and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases.
PHARMACEUTICAL PREPARATIONSSIC 283412 employeesKIRYAT ATIDIM, BUILDING 7, TEL AVIV, L3, 6158002972-77-331-0156IPO Mar 17, 2021US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001534248
- Composite FIGI
- BBG00N0PMGK1
- Share Class FIGI
- BBG00N0PMH92
- Ticker Root
- CMMB
- SIC Code
- 2834
About Chemomab Therapeutics Ltd. American Depositary Share (CMMB) Stock
Chemomab Therapeutics Ltd. American Depositary Share (CMMB) closed the 2026-09-17 session at $2.80, up 5.66% versus the previous close (+0.15). The stock opened at $2.74 and traded between $2.56 and $2.80 during that session. Session trading volume was 131K shares. The volume-weighted average price (VWAP) is $2.64.
Chemomab Therapeutics Ltd is a clinical-stage biotechnology company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin, and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases.
Chemomab Therapeutics Ltd. American Depositary Share has a market capitalization of $19.4 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. CMMB is listed on the XNAS exchange. The company employs approximately 12 people. Chemomab Therapeutics Ltd. American Depositary Share is headquartered in TEL AVIV, L3. The recorded listing date is 2021-03-17.
On this page you can find market CMMB stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.